Castleman's disease in a renal allograft recipient. 1997

S Cagirgan, and M Cirit, and E Ok, and M Sencan, and M Hekimgil, and A Unsal, and G Saydam, and Y Tokat

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008297 Male Males
D005871 Castleman Disease Large benign, hyperplastic lymph nodes. The more common hyaline vascular subtype is characterized by small hyaline vascular follicles and interfollicular capillary proliferations. Plasma cells are often present and represent another subtype with the plasma cells containing IgM and IMMUNOGLOBULIN A. Angiofollicular Lymphoid Hyperplasia,Castleman's Tumor,Giant Lymph Node Hyperplasia,Hyperplasia, Giant Lymph Node,Lymph Node Hyperplasia, Giant,Angiofollicular Lymph Hyperplasia,Angiofollicular Lymph Node Hyperplasia,Castleman's Disease,Castlemans Disease,Angiofollicular Lymph Hyperplasias,Angiofollicular Lymphoid Hyperplasias,Castleman Tumor,Castlemans Tumor,Disease, Castlemans,Hyperplasia, Angiofollicular Lymph,Hyperplasia, Angiofollicular Lymphoid,Lymph Hyperplasia, Angiofollicular,Lymphoid Hyperplasia, Angiofollicular,Tumor, Castleman's
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016030 Kidney Transplantation The transference of a kidney from one human or animal to another. Grafting, Kidney,Renal Transplantation,Transplantation, Kidney,Transplantation, Renal,Kidney Grafting,Kidney Transplantations,Renal Transplantations,Transplantations, Kidney,Transplantations, Renal
D017809 Fatal Outcome Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept. Fatal Outcomes,Outcome, Fatal,Outcomes, Fatal

Related Publications

S Cagirgan, and M Cirit, and E Ok, and M Sencan, and M Hekimgil, and A Unsal, and G Saydam, and Y Tokat
February 2020, The Journal of international medical research,
S Cagirgan, and M Cirit, and E Ok, and M Sencan, and M Hekimgil, and A Unsal, and G Saydam, and Y Tokat
January 2020, Best practice & research. Clinical gastroenterology,
S Cagirgan, and M Cirit, and E Ok, and M Sencan, and M Hekimgil, and A Unsal, and G Saydam, and Y Tokat
November 2009, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia,
S Cagirgan, and M Cirit, and E Ok, and M Sencan, and M Hekimgil, and A Unsal, and G Saydam, and Y Tokat
May 2013, Indian journal of nephrology,
S Cagirgan, and M Cirit, and E Ok, and M Sencan, and M Hekimgil, and A Unsal, and G Saydam, and Y Tokat
January 2009, Indian journal of nephrology,
S Cagirgan, and M Cirit, and E Ok, and M Sencan, and M Hekimgil, and A Unsal, and G Saydam, and Y Tokat
March 2014, Indian journal of nephrology,
S Cagirgan, and M Cirit, and E Ok, and M Sencan, and M Hekimgil, and A Unsal, and G Saydam, and Y Tokat
January 2015, Indian journal of nephrology,
S Cagirgan, and M Cirit, and E Ok, and M Sencan, and M Hekimgil, and A Unsal, and G Saydam, and Y Tokat
September 1989, Transplantation,
S Cagirgan, and M Cirit, and E Ok, and M Sencan, and M Hekimgil, and A Unsal, and G Saydam, and Y Tokat
January 1994, Nephron,
S Cagirgan, and M Cirit, and E Ok, and M Sencan, and M Hekimgil, and A Unsal, and G Saydam, and Y Tokat
June 2010, NDT plus,
Copied contents to your clipboard!